# Bioorganic Approaches Toward Novel Antimicrobial Agents and Chemotherapeutics

> **NIH NIH R35** · VANDERBILT UNIVERSITY · 2024 · $451,462

## Abstract

Project Summary / Abstract
The goal of our laboratory is to interface challenging and thought-provoking organic chemistry
with issues of plausible biological application. A primary goal for the next five years is to develop
new molecular probes and leverage these molecules to advance our understanding of human
disease. Critical to the role which the laboratory plays at Vanderbilt University, and within larger
concerns of glycobiology, is problem selection. On the chemistry side, we identify problems of a
complexity level conducive to new and significant learning experiences. At the level of biology,
we select difficult problems that may be subject to accelerated advance if the necessary chemistry
can be developed. Taken together, the overall vision for our program is to apply a human health
driven approach to developing robust and reproducible reactions and synthesis strategies to
interrogate clinically relevant diseases.

## Key facts

- **NIH application ID:** 10841864
- **Project number:** 2R35GM133602-06
- **Recipient organization:** VANDERBILT UNIVERSITY
- **Principal Investigator:** Steven D. Townsend
- **Activity code:** R35 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $451,462
- **Award type:** 2
- **Project period:** 2019-09-01 → 2029-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10841864

## Citation

> US National Institutes of Health, RePORTER application 10841864, Bioorganic Approaches Toward Novel Antimicrobial Agents and Chemotherapeutics (2R35GM133602-06). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10841864. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*